Dartmouth researchers characterized 5-methylcytosine and 5-hydroxymethylcytosine marks in more than two dozen glioblastoma samples.
Researchers have released new tools for analyzing epigenomic data as part of the International Human Epigenome Consortium.
In Genome Biology this week: single-cell transcriptomic study of embryonic stem cell differentiation, epigenome-wide association study of schizophrenia, and more.
"Gene doping" may be the next method athletes use to give themselves an edge.
The assay captures modification states with antibodies targeting histone modifications while single-molecule sequencing reveals the genomic location.
Researchers have found nearly 175 genomic loci that are differentially methylated in people with schizophrenia.
In a paper published today in Nature Methods, the researchers applied scM&T-seq to profile the transcriptomes and epigenomes of mouse embryonic stem cells.
University of Liverpool researchers analyzed methylation in the wheat genome to find variations in subgenome-specific methylation.
Epigenomics is also seeking approval from the FDA for the Epi proColon test.
NEW YORK (GenomeWeb) – Epigenomics today said that its third quarter revenues grew 7 percent year over year as the firm progresses in its efforts to gain regulatory approval of its colorectal cancer molecular diagnostic test.
In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.
Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.
In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.
Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.